Health Condition 1: null- Chronic spontaneous urticaria
Conditions
Interventions
Intervention1: Levocetrizine: All patients will be treated with levocetirizine 5mg per day. Those patients whose symptoms are not completely controlled with 5mg levocetirizine, will be treated with we
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients >18 years of age 2.Patients fulfilling the definition of chronic spontaneous urticaria which is urticarial lesions occurring most days of the week (atleast 3 times a week) lasting for 6 weeks or more with no identifiable cause on history or examination.
Exclusion criteria
Exclusion criteria: 1. Patients less than 18 years of age, 2. Patients unwilling to participate in the study, 3. Patients with physical, contact, drug-induced urticaria and urticarial vasculitis 4. Pregnant or breast-feeding females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients achieving complete control of urticaria with varying doses of antihistaminesTimepoint: From September 2014 to September 2015 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Change in Urticaria Activity Score (UAS7) â?¢Change in quality-of-life as measured by CUQ2oL â?¢Degree of sedation experienced as reported by the patients Timepoint: From September 2014 to September 2015 | — |
Countries
India
Contacts
Public ContactDr Vinod Kumar Sharma
Dermatology and Venereology, AIIMS
Outcome results
None listed